D N Bateman1. Show Affiliations » 1. Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne.
Abstract
Mesh: See more » 2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer Agents/adverse effectsAnti-Ulcer Agents/therapeutic useBenzimidazoles/adverse effectsBenzimidazoles/therapeutic useEnzyme Inhibitors/adverse effectsEnzyme Inhibitors/therapeutic useHumansLansoprazoleOmeprazole/adverse effectsOmeprazole/analogs & derivativesOmeprazole/therapeutic usePantoprazolePeptic Ulcer/drug therapyProton Pump InhibitorsSulfoxides/adverse effectsSulfoxides/therapeutic use
Substances: See more » 2-PyridinylmethylsulfinylbenzimidazolesAnti-Ulcer AgentsBenzimidazolesEnzyme InhibitorsProton Pump InhibitorsSulfoxidesLansoprazolePantoprazoleOmeprazole
Year: 1997 PMID: 9186377 DOI: 10.1016/s0140-6736(05)62629-3
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321